Karen Deane

803 total citations
20 papers, 610 citations indexed

About

Karen Deane is a scholar working on Oncology, Genetics and Social Psychology. According to data from OpenAlex, Karen Deane has authored 20 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Genetics and 4 papers in Social Psychology. Recurrent topics in Karen Deane's work include Cancer survivorship and care (6 papers), BRCA gene mutations in cancer (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Karen Deane is often cited by papers focused on Cancer survivorship and care (6 papers), BRCA gene mutations in cancer (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Karen Deane collaborates with scholars based in Canada, United States and United Kingdom. Karen Deane's co-authors include Margaret I. Fitch, H. Sharon Campbell, Doris Howell, Lesley F. Degner, Ross E. Gray, Elizabeth J. Carey, Marlyn J. Mayo, Christopher L. Bowlus, Cynthia Levy and W. Ray Kim and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Patient Education and Counseling.

In The Last Decade

Karen Deane

18 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Deane Canada 11 276 195 164 146 108 20 610
Robin M. Lally United States 16 418 1.5× 312 1.6× 191 1.2× 109 0.7× 223 2.1× 52 884
Ragnhild Johanne Tveit Sekse Norway 11 225 0.8× 176 0.9× 224 1.4× 140 1.0× 248 2.3× 26 718
PN Butow Australia 6 450 1.6× 113 0.6× 213 1.3× 220 1.5× 157 1.5× 13 596
M Wilmoth United States 14 433 1.6× 162 0.8× 223 1.4× 140 1.0× 113 1.0× 34 721
Shannon Myers Virtue United States 18 364 1.3× 202 1.0× 281 1.7× 217 1.5× 176 1.6× 39 810
Ceri Phelps United Kingdom 12 91 0.3× 137 0.7× 85 0.5× 70 0.5× 80 0.7× 23 476
Jill Taylor‐Brown Canada 17 332 1.2× 136 0.7× 289 1.8× 223 1.5× 253 2.3× 19 685
Andrea A. Thornton United States 13 383 1.4× 137 0.7× 251 1.5× 256 1.8× 189 1.8× 17 895
Francisco Gil Spain 14 353 1.3× 164 0.8× 134 0.8× 211 1.4× 200 1.9× 33 669
Sandra Ieropoli Australia 6 180 0.7× 156 0.8× 126 0.8× 130 0.9× 112 1.0× 7 442

Countries citing papers authored by Karen Deane

Since Specialization
Citations

This map shows the geographic impact of Karen Deane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Deane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Deane more than expected).

Fields of papers citing papers by Karen Deane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Deane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Deane. The network helps show where Karen Deane may publish in the future.

Co-authorship network of co-authors of Karen Deane

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Deane. A scholar is included among the top collaborators of Karen Deane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Deane. Karen Deane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mayo, Marlyn J., Christopher L. Bowlus, Elizabeth J. Carey, et al.. (2019). FRI-043-Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort. Journal of Hepatology. 70(1). e403–e403. 1 indexed citations
3.
Levy, Cynthia, Marlyn J. Mayo, Elizabeth J. Carey, et al.. (2019). Mo1475 – Change in Lipids: Characteristics and Response to Obeticholic Acid (OCA) in Target-PBC, a Diverse, Large United States (US) Real-World Cohort. Gastroenterology. 156(6). S–1319. 1 indexed citations
4.
Levy, Cynthia, Marlyn J. Mayo, Elizabeth J. Carey, et al.. (2019). FRI-037-Change in lipids: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort. Journal of Hepatology. 70(1). e400–e400. 1 indexed citations
5.
Bowlus, Christopher L., Elizabeth J. Carey, George R. DeMuth, et al.. (2018). Primary biliary cholangitis (PBC) in the U.S.: real world effectiveness of obeticholic acid in TARGET-PBC. Journal of Hepatology. 68. S228–S229.
6.
Levy, Cynthia, Christopher L. Bowlus, Elizabeth J. Carey, et al.. (2018). A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale. Hepatology Communications. 2(5). 484–491. 10 indexed citations
7.
Campbell, H. Sharon, et al.. (2004). Cancer peer support programs—do they work?. Patient Education and Counseling. 55(1). 3–15. 218 indexed citations
8.
Fitch, Margaret I., Karen Deane, & Doris Howell. (2003). Living with ovarian cancer: Women’s perspectives on treatment and treatment decision-making. Canadian Oncology Nursing Journal. 13(1). 8–13. 15 indexed citations
9.
Howell, Doris, Margaret I. Fitch, & Karen Deane. (2003). Impact of Ovarian Cancer Perceived by Women. Cancer Nursing. 26(1). 1–9. 66 indexed citations
10.
Fitch, Margaret I., Karen Deane, Doris Howell, & Ross E. Gray. (2003). Women’s experiences with ovarian cancer: Reflections on being diagnosed. Canadian Oncology Nursing Journal. 12(3). 152–159. 46 indexed citations
11.
Howell, Doris, Margaret I. Fitch, & Karen Deane. (2003). Women’s Experiences With Recurrent Ovarian Cancer. Cancer Nursing. 26(1). 10–17. 55 indexed citations
12.
Fitch, Margaret I., Karen Deane, Doris Howell, & Ross E. Gray. (2003). Le vécu du cancer ovarien: réflexions sur la phase diagnostique. Canadian Oncology Nursing Journal. 12(3). 160–168. 1 indexed citations
13.
Fitch, Margaret I., Karen Deane, & Doris Howell. (2003). Le vécu du cancer ovarien: les perspectives des femmes sur le traitement et la prise de décision thérapeutique. Canadian Oncology Nursing Journal. 13(1). 14–20. 3 indexed citations
14.
Deane, Karen, et al.. (2000). An innovative art therapy program for cancer patients. Canadian Oncology Nursing Journal. 10(4). 147–151. 34 indexed citations
15.
Deane, Karen, et al.. (2000). The cancer journey: Bridging art therapy and museum education. Canadian Oncology Nursing Journal. 10(4). 140–142. 21 indexed citations
16.
Deane, Karen, et al.. (2000). Un programme d'art thérapie innovateur destiné aux patients atteints de cancer. Canadian Oncology Nursing Journal. 10(4). 152–157. 1 indexed citations
17.
Deane, Karen & Lesley F. Degner. (1998). Information needs, uncertainty, and anxiety in women who had a breast biopsy with benign outcome. Cancer Nursing. 21(2). 117–126. 79 indexed citations
18.
Deane, Karen & Lesley F. Degner. (1997). Determining the Information Needs of Women After Breast Biopsy Procedures. AORN Journal. 65(4). 767–776. 23 indexed citations
19.
Deane, Karen. (1997). The Role of the Breast Clinic Nurse. AORN Journal. 66(2). 304–310. 5 indexed citations
20.
Deane, Karen. (1991). A framework for decision making.. PubMed. 14(6). 15–7. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026